关于复立
宁波复立保险科技有限公司暨宁波复立保险科技研究院，具有政府、学术、产业三方合作的复合式的股东。
宁波市是国务院唯一指定的保险科技示范城市，依托宁波先试先行的政策导向，借助高校学术研究的支持，同时发挥保险科技创业者的实践积累，力图通过多方位的保险科技长信手段，解决传统保险的痛点，充分发挥保险的民生保障作用。
发展历程
宁波复立保险科技有限公司，暨宁波复立保险科技研究院，于2018年正式成立。
由宁波市副市长刘长春、宁波市金融办主任姚蓓军、宁波保监局局长赵巍、鄞州区副区长梅益进等领导正式揭牌。
正式启动复立云平台项目，为保险行业输出保险产品设计、AI保顾、精准营销等服务。该项目已入选宁波泛3315计划。
2019年1月，宁波复立保险科技有限公司成功挂牌宁波股权交易所创新版，企业简称“复立科技”，挂牌代码781660.
启动健康险直赔项目。嫁接医院与保险公司，已在河南、安徽、宁波等地启动试点工作。
完成千万级A轮融资。
始终探索于新兴技术在保险领域得落地，持续向行业输出降本增效、普惠民生的产品和服务。
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus convallis at tellus.
Pellentesque in ipsum id orci porta dapibus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus.
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus convallis at tellus.
Pellentesque in ipsum id orci porta dapibus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus.
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus convallis at tellus.
Pellentesque in ipsum id orci porta dapibus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus.
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus convallis at tellus.
Pellentesque in ipsum id orci porta dapibus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus.
Vivamus magna justo, lacinia eget consectetur sed, convallis at tellus.
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
FDA Approves Bayer's Finacea® Foam, 15% for the Topical Treatment of the Inflammatory.
In two pivotal clinical trials, treatment with resulted in a higher Investigator's Global Assessment.
How to plan your Budget?
成立背景
宁波市鄞州区国资委下属产投基金参与发起复立。
来自于复旦大学，上海立信会计金融学院的多位教授、导师参与发起复立。
多名保险科技与金融科技的连续创业者参与发起复立
新闻报道
合作伙伴
联系方式
最新报道
